This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kozlowski, M.
Right arrow Articles by Siminovitch, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kozlowski, M.
Right arrow Articles by Siminovitch, K. A.

 Previous Article  |  Next Article 

Mol Cell Biol, April 1998, p. 2089-2099, Vol. 18, No. 4
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

SHP-1 Binds and Negatively Modulates the c-Kit Receptor by Interaction with Tyrosine 569 in the c-Kit Juxtamembrane Domain

Maya Kozlowski,1,* Louise Larose,2 Fai Lee,1 Duc Mingh Le,1 Robert Rottapel,3 and Katherine A. Siminovitch4

Health Canada Life Sciences and the University of Ottawa, Ottawa,1 Polypeptide Hormone Laboratory, McGill University, Montreal,2 and Departments of Medicine, Immunology and Medical Genetics and Microbiology, University of Toronto, the Wellesley Hospital Research Institute, Wellesley Hospital,3 and the Samuel Lunenfeld Research Institute, Mount Sinai Hospital,4 Toronto, Canada

Received 17 July 1997/Returned for modification 1 September 1997/Accepted 22 December 1997

The SH2 domain-containing SHP-1 tyrosine phosphatase has been shown to negatively regulate a broad spectrum of growth factor- and cytokine-driven mitogenic signaling pathways. Included among these is the cascade of intracellular events evoked by stem cell factor binding to c-Kit, a tyrosine kinase receptor which associates with and is dephosphorylated by SHP-1. Using a series of glutathione S-transferase (GST) fusion proteins containing either tyrosine-phosphorylated segments of the c-Kit cytosolic region or the SH2 domains of SHP-1, we have shown that SHP-1 interacts with c-Kit by binding selectively to the phosphorylated c-Kit juxtamembrane region and that the association of c-Kit with the larger of the two SHP-1 isoforms may be mediated through either the N-terminal or C-terminal SHP-1 SH2 domain. The results of binding assays with mutagenized GST-Kit juxtamembrane fusion proteins and competitive inhibition assays with phosphopeptides encompassing each c-Kit juxtamembrane region identified the tyrosine residue at position 569 as the major site for binding of SHP-1 to c-Kit and suggested that tyrosine 567 contributes to, but is not required for, this interaction. By analysis of Ba/F3 cells retrovirally transduced to express c-Kit receptors, phenylalanine substitution of c-Kit tyrosine residue 569 was shown to be associated with disruption of c-Kit-SHP-1 binding and induction of hyperproliferative responses to stem cell factor. Although phenylalanine substitution of c-Kit tyrosine residue 567 in the Ba/F3-c-Kit cells did not alter SHP-1 binding to c-Kit, the capacity of a second c-Kit-binding tyrosine phosphatase, SHP-2, to associate with c-Kit was markedly reduced, and the cells again showed hyperproliferative responses to stem cell factor. These data therefore identify SHP-1 binding to tyrosine 569 on c-Kit as an interaction pivotal to SHP-1 inhibitory effects on c-Kit signaling, but they indicate as well that cytosolic protein tyrosine phosphatases other than SHP-1 may also negatively regulate the coupling of c-Kit engagement to proliferation.


* Corresponding author. Mailing address: Life Sciences Division, Tunney's Pasture, Ottawa K1A 0L2, Canada. Phone: (613) 941-6594. Fax: (613) 941-8933. E-mail: Maya_Kozlowski{at}hc-sc.gc.ca.




This article has been cited by other articles:

  • Sun, J., Pedersen, M., Ronnstrand, L. (2009). The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction. J. Biol. Chem. 284: 11039-11047 [Abstract] [Full Text]  
  • Kent, D., Copley, M., Benz, C., Dykstra, B., Bowie, M., Eaves, C. (2008). Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling Pathway. Clin. Cancer Res. 14: 1926-1930 [Abstract] [Full Text]  
  • Corbacioglu, S., Kilic, M., Westhoff, M.-A., Reinhardt, D., Fulda, S., Debatin, K.-M. (2006). Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin. Blood 108: 3504-3513 [Abstract] [Full Text]  
  • Yu, M., Luo, J., Yang, W., Wang, Y., Mizuki, M., Kanakura, Y., Besmer, P., Neel, B. G., Gu, H. (2006). The Scaffolding Adapter Gab2, via Shp-2, Regulates Kit-evoked Mast Cell Proliferation by Activating the Rac/JNK Pathway. J. Biol. Chem. 281: 28615-28626 [Abstract] [Full Text]  
  • Osajima-Hakomori, Y., Miyake, I., Ohira, M., Nakagawara, A., Nakagawa, A., Sakai, R. (2005). Biological Role of Anaplastic Lymphoma Kinase in Neuroblastoma. Am. J. Pathol. 167: 213-222 [Abstract] [Full Text]  
  • Florian, S., Ghannadan, M., Mayerhofer, M., Aichberger, K. J., Hauswirth, A. W., Schernthaner, G.-H., Printz, D., Fritsch, G., Bohm, A., Sonneck, K., Krauth, M.-T., Muller, M. R., Sillaber, C., Sperr, W. R., Buhring, H.-J., Valent, P. (2005). Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRP{alpha}), CD47, and SHP-1. J. Leukoc. Biol. 77: 984-992 [Abstract] [Full Text]  
  • Roccato, E., Miranda, C., Raho, G., Pagliardini, S., Pierotti, M. A., Greco, A. (2005). Analysis of SHP-1-mediated Down-regulation of the TRK-T3 Oncoprotein Identifies Trk-fused Gene (TFG) as a Novel SHP-1-interacting Protein. J. Biol. Chem. 280: 3382-3389 [Abstract] [Full Text]  
  • Rohde, C. M., Schrum, J., Lee, A. W.-M. (2004). A Juxtamembrane Tyrosine in the Colony Stimulating Factor-1 Receptor Regulates Ligand-induced Src Association, Receptor Kinase Function, and Down-regulation. J. Biol. Chem. 279: 43448-43461 [Abstract] [Full Text]  
  • Biskup, C., Bohmer, A., Pusch, R., Kelbauskas, L., Gorshokov, A., Majoul, I., Lindenau, J., Benndorf, K., Bohmer, F.-D. (2004). Visualization of SHP-1-target interaction. J. Cell Sci. 117: 5165-5178 [Abstract] [Full Text]  
  • Slominski, A., Tobin, D. J., Shibahara, S., Wortsman, J. (2004). Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation. Physiol. Rev. 84: 1155-1228 [Abstract] [Full Text]  
  • Mol, C. D., Dougan, D. R., Schneider, T. R., Skene, R. J., Kraus, M. L., Scheibe, D. N., Snell, G. P., Zou, H., Sang, B.-C., Wilson, K. P. (2004). Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase. J. Biol. Chem. 279: 31655-31663 [Abstract] [Full Text]  
  • Kimura, Y., Jones, N., Kluppel, M., Hirashima, M., Tachibana, K., Cohn, J. B., Wrana, J. L., Pawson, T., Bernstein, A. (2004). Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages. Proc. Natl. Acad. Sci. USA 101: 6015-6020 [Abstract] [Full Text]  
  • Bayle, J., Letard, S., Frank, R., Dubreuil, P., De Sepulveda, P. (2004). Suppressor of Cytokine Signaling 6 Associates with KIT and Regulates KIT Receptor Signaling. J. Biol. Chem. 279: 12249-12259 [Abstract] [Full Text]  
  • Frank, C., Burkhardt, C., Imhof, D., Ringel, J., Zschornig, O., Wieligmann, K., Zacharias, M., Bohmer, F.-D. (2004). Effective Dephosphorylation of Src Substrates by SHP-1. J. Biol. Chem. 279: 11375-11383 [Abstract] [Full Text]  
  • Agosti, V., Corbacioglu, S., Ehlers, I., Waskow, C., Sommer, G., Berrozpe, G., Kissel, H., Tucker, C. M., Manova, K., Moore, M. A.S., Rodewald, H.-R., Besmer, P. (2004). Critical Role for Kit-mediated Src Kinase But Not PI 3-Kinase Signaling in Pro T and Pro B Cell Development. JEM 199: 867-878 [Abstract] [Full Text]  
  • Kellie, S., Craggs, G., Bird, I. N., Jones, G. E. (2004). The tyrosine phosphatase DEP-1 induces cytoskeletal rearrangements, aberrant cell-substratum interactions and a reduction in cell proliferation. J. Cell Sci. 117: 609-618 [Abstract] [Full Text]  
  • Behbod, F., Nagy, Z. S., Stepkowski, S. M., Karras, J., Johnson, C. R., Jarvis, W. D., Kirken, R. A. (2003). Specific Inhibition of Stat5a/b Promotes Apoptosis of IL-2-Responsive Primary and Tumor-Derived Lymphoid Cells. J. Immunol. 171: 3919-3927 [Abstract] [Full Text]  
  • Mol, C. D., Lim, K. B., Sridhar, V., Zou, H., Chien, E. Y. T., Sang, B.-C., Nowakowski, J., Kassel, D. B., Cronin, C. N., McRee, D. E. (2003). Structure of a c-Kit Product Complex Reveals the Basis for Kinase Transactivation. J. Biol. Chem. 278: 31461-31464 [Abstract] [Full Text]  
  • Chan, P. M., Ilangumaran, S., La Rose, J., Chakrabartty, A., Rottapel, R. (2003). Autoinhibition of the Kit Receptor Tyrosine Kinase by the Cytosolic Juxtamembrane Region. Mol. Cell. Biol. 23: 3067-3078 [Abstract] [Full Text]  
  • Voytyuk, O., Lennartsson, J., Mogi, A., Caruana, G., Courtneidge, S., Ashman, L. K., Ronnstrand, L. (2003). Src Family Kinases Are Involved in the Differential Signaling from Two Splice Forms of c-Kit. J. Biol. Chem. 278: 9159-9166 [Abstract] [Full Text]  
  • Frost, M. J., Ferrao, P. T., Hughes, T. P., Ashman, L. K. (2002). Juxtamembrane Mutant V560GKit Is More Sensitive to Imatinib (STI571) Compared with Wild-Type c-Kit Whereas the Kinase Domain Mutant D816VKit Is Resistant. Molecular Cancer Therapeutics 1: 1115-1124 [Abstract] [Full Text]  
  • Ueda, S., Mizuki, M., Ikeda, H., Tsujimura, T., Matsumura, I., Nakano, K., Daino, H., Honda, Z.-i., Sonoyama, J., Shibayama, H., Sugahara, H., Machii, T., Kanakura, Y. (2002). Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration. Blood 99: 3342-3349 [Abstract] [Full Text]  
  • Taylor, M. L., Dastych, J., Sehgal, D., Sundstrom, M., Nilsson, G., Akin, C., Mage, R. G., Metcalfe, D. D. (2001). The Kit-activating mutation D816V enhances stem cell factor-dependent chemotaxis. Blood 98: 1195-1199 [Abstract] [Full Text]  
  • Beghini, A., Ripamonti, C. B., Peterlongo, P., Roversi, G., Cairoli, R., Morra, E., Larizza, L. (2000). RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum Mol Genet 9: 2297-2304 [Abstract] [Full Text]  
  • Bondzi, C., Litz, J., Dent, P., Krystal, G. W. (2000). Src Family Kinase Activity Is Required for Kit-mediated Mitogen-activated Protein (MAP) Kinase Activation, However Loss of Functional Retinoblastoma Protein Makes MAP Kinase Activation Unnecessary for Growth of Small Cell Lung Cancer Cells. Cell Growth Differ. 11: 305-314 [Abstract] [Full Text]  
  • Huang, H., Paul, W. E. (2000). Protein Tyrosine Phosphatase Activity Is Required for IL-4 Induction of IL-4 Receptor {alpha}-Chain. J. Immunol. 164: 1211-1215 [Abstract] [Full Text]  
  • Ward, A. C., Touw, I., Yoshimura, A. (2000). The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 95: 19-29 [Full Text]  
  • Cuevas, B., Lu, Y., Watt, S., Kumar, R., Zhang, J., Siminovitch, K. A., Mills, G. B. (1999). SHP-1 Regulates Lck-induced Phosphatidylinositol 3-Kinase Phosphorylation and Activity. J. Biol. Chem. 274: 27583-27589 [Abstract] [Full Text]  
  • Broudy, V. C., Lin, N. L., Liles, W. C., Corey, S. J., O'Laughlin, B., Mou, S., Linnekin, D. (1999). Signaling via Src Family Kinases Is Required for Normal Internalization of the Receptor c-Kit. Blood 94: 1979-1986 [Abstract] [Full Text]  
  • Taniguchi, Y., London, R., Schinkmann, K., Jiang, S., Avraham, H. (1999). The Receptor Protein Tyrosine Phosphatase, PTP-RO, Is Upregulated During Megakaryocyte Differentiation and Is Associated With the c-Kit Receptor. Blood 94: 539-549 [Abstract] [Full Text]  
  • Chiang, G. G., Sefton, B. M. (2001). Specific Dephosphorylation of the Lck Tyrosine Protein Kinase at Tyr-394 by the SHP-1 Protein-tyrosine Phosphatase. J. Biol. Chem. 276: 23173-23178 [Abstract] [Full Text]